Send feedback

HBD p.Ala28Ser

c.82G>T · rs35152987 · VCV15070

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 10 submitters
AlphaMissense
likely benign
0.2001 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.643%, mid)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
3
Fetal hemoglobin quantitative trait locus 1

Computational evidence

Protein change
AlphaMissense0.2001likely benign
REVEL0.636indeterminate
SaProtLLR -9.79tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAIΔ0.67donor gain · deltas
PangolinΔ0.60gain · loss 0.32 · agrees with SpliceAI · independent
Constraint at this position
ConservationphyloP -20GERP -3.4
Regional constrainto/e 1.08unconstrained · MANE · 1,466 bp · p 0.27 · regional, not allelic
Overall
CADD19.23PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.643% Middle Eastern · 39/6,062 alleles
Filtering AF 0.484% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.428%
Overall 0.187% 3,024/1,613,812 alleles · rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.753% 133
Middle Easterngrpmax 0.643% 155
South Asian 0.395% 253
Remaining individualsnot grpmax-eligible 0.23% 434
European (non-Finnish) 0.176% 569
Finnishnot grpmax-eligible 0.125% 800
Admixed American 0.118% 845
African / African-American 0.0427% 2,344

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
HBD
Protein
p.Ala28Ser
Coding
c.82G>T
MANE Select
NM_000519
dbSNP
rs35152987
Type
single nucleotide variant
Location
chr11:5234352 (GRCh38)
Gene constraint
LOEUF 1.586 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 96.81 · 2 PDB
Residue 28
the globin domain; a UniProt-annotated variant site (in yialousa); an α-helix
Full HBD gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/hbd-p-ala28ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown